Medical Xpress·3 min read·hard
Intratumoral Fusobacterium as a prognostic and predictive biomarker in resectable colorectal cancer
V
Vall d'Hebron Institute of Oncology
✦AI Summary
A study by the FUSOMAP project has identified the presence of Fusobacterium in colorectal tumors as a biomarker for more aggressive cancer subtypes. Patients with this bacteria show a weaker immune response and limited benefit from standard chemotherapy.
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in